Search Within

Brian Carl Shaffer

  1. "2016"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (3)
Groups
  1. Bone Marrow Transplant (13)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Survivorship Research (10)
  6. Biostatistics Service (9)

More Groups

People
  1. Miguel-Angel Perales (11)
  2. Sergio Giralt (10)
  3. Boglarka Gyurkocza (9)
  4. Roni Tamari (9)
  5. Hugo Castro-Malaspina (8)
  6. Sean Devlin (8)

More People

Years
  1. 2016 (13)
Publications
  1. Blood (5)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Bone Marrow Transplantation (3)
  4. Best Practice and Research: Clinical Haematology (1)
  5. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • How important is NK alloreactivity and KIR in allogeneic transplantation?
    Journal Article

    Shaffer, B. C.; Hsu, K. C.
    Best Practice and Research: Clinical Haematology (2016)

    Fulltext@MSK | Save
  • Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Journal Article

    Shaffer, B. C.; Tallman, M.; Malone, A. K.; Reshef, R.; Litzow, M.; Liesveld, J.; Wiernik, P. H.; Ahn, K. W.; Hu, Z. H.; Saber, W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Acute toxicities in patients receiving ex-vivo CD34+ selected allogeneic stem cell transplantation for hematologic malignancies
    Meeting Abstract

    Herrera, D.; Perales, M. A.; Shah, G.; Scordo, M.; Devlin, S.; Maloy, M.; Nieves, J.; Avecilla, S.; Meagher, R.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save